Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)

Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO) develops, manufactures, markets, and distributes pharmaceutical products and medical appliances. Its portfolio includes general medicines, specialty medicines, vaccines, biologics, antibiotics, oncology products, antiseptics, and biosimilar products. Available dosage forms include capsules, tablets, liquids, suppositories, medical creams and ointments, pre-filled syringes, and sterile ampoules and vials. The company reports a portfolio of more than 400 products across multiple therapeutic categories, serving healthcare needs through hospitals, pharmacies, clinics, healthcare providers, distributors, and government health initiatives.

Established in 1986, the Saudi joint-stock company operates seven manufacturing facilities across four countries and serves 21 markets in the Middle East and North Africa. Its facilities have production capacity exceeding 2.3 billion units annually, supported by automated production lines, an automated warehouse, and a drug development center in Qassim. Research and development activities include generic product development, non-infringing formulations, technology transfer evaluation, stability studies, bioequivalence studies, and registration-file preparation. Quality operations integrate GMP and quality management systems, supplier qualification, technology transfer, and risk management. The company holds ISO 9001, ISO 45001, and ISO 14001 certifications, while its quality control laboratory holds ISO 17025 accreditation from the International Accreditation Service.